AU3210477A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU3210477A
AU3210477A AU32104/77A AU3210477A AU3210477A AU 3210477 A AU3210477 A AU 3210477A AU 32104/77 A AU32104/77 A AU 32104/77A AU 3210477 A AU3210477 A AU 3210477A AU 3210477 A AU3210477 A AU 3210477A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU32104/77A
Inventor
Carsten Dr Materne
Hans Dr Betzing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of AU3210477A publication Critical patent/AU3210477A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32104/77A 1976-12-30 1977-12-30 Pharmaceutical composition Pending AU3210477A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762659666 DE2659666A1 (en) 1976-12-30 1976-12-30 MEDICINAL PRODUCTS THAT PROVIDE BLOOD

Publications (1)

Publication Number Publication Date
AU3210477A true AU3210477A (en) 1979-07-05

Family

ID=5997096

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32104/77A Pending AU3210477A (en) 1976-12-30 1977-12-30 Pharmaceutical composition

Country Status (5)

Country Link
JP (1) JPS5394039A (en)
AU (1) AU3210477A (en)
DE (1) DE2659666A1 (en)
FR (1) FR2375862A1 (en)
ZA (1) ZA777701B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134240A0 (en) * 2000-01-27 2001-04-30 Senyorina Ltd Inositol derivatives and their pharmaceutical use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD122524A1 (en) * 1975-10-17 1976-10-12

Also Published As

Publication number Publication date
JPS5394039A (en) 1978-08-17
FR2375862A1 (en) 1978-07-28
ZA777701B (en) 1978-11-29
DE2659666A1 (en) 1978-07-13

Similar Documents

Publication Publication Date Title
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
ZA774920B (en) Pharmaceutical compositions
JPS5362838A (en) Pharmaceutical composition
AU515341B2 (en) Pharmaceutical composition
PT66622B (en) Pharmaceutical compositions
JPS5372814A (en) Pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
AU3152677A (en) Pharmaceutical composition
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
NZ186147A (en) Sterolin pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
AU2649977A (en) Pharmaceutical composition
JPS5356634A (en) Pharmaceutical composition
AU508191B2 (en) Pharmaceutical composition
ZA772612B (en) Pharmaceutical compositions
HK69380A (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
JPS5283918A (en) Pharmaceutical composition
HK3984A (en) Pharmaceutical compositions
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions
ZA771408B (en) Pharmaceutical compositions
JPS52122633A (en) Pharmaceutical composition
ZA777335B (en) Pharmaceutical compounds
AU3210477A (en) Pharmaceutical composition